Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  29 (2025)
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 28 , ISSUE 12 ( December, 2024 ) > List of Articles

Original Article

Study of the Role of C-reactive Protein/Procalcitonin Ratio as a Prognostic Tool in ICU Patients with Sepsis: A Prospective Observational Study

Eman M Abdellatif, Emad H Hamouda

Keywords : C-reactive protein/PCT ratio, Intensive care unit, Procalcitonin, Prognosis, Sepsis, SOFA score

Citation Information : Abdellatif EM, Hamouda EH. Study of the Role of C-reactive Protein/Procalcitonin Ratio as a Prognostic Tool in ICU Patients with Sepsis: A Prospective Observational Study. Indian J Crit Care Med 2024; 28 (12):1130-1138.

DOI: 10.5005/jp-journals-10071-24855

License: CC BY-NC 4.0

Published Online: 30-11-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: Prediction of prognosis in sepsis is an essential research area aiming to improve disease outcomes. In this study, we investigated the role of the C-reactive protein (CRP)/procalcitonin (PCT) ratio as a prognostic tool in sepsis patients. Materials and methods: This prospective observational study was conducted at the intensive care unit (ICU) of Alexandria Main University Hospital in the period from January to June 2024. One hundred and seventy patients with a diagnosis of sepsis were enrolled. Sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation (APACHEII) score and CRP/PCT ratio were calculated on admission (day 1), and as a follow-up on day 3. Patients were subsequently divided into survivor and non-survivor groups, and the data were compared. Results: The CRP/PCT ratio was significantly lower, on admission and on follow-up, in non-survivor patients than in survivor patients. The ratio median (minimum–maximum) in non-survivors was 4.82 (1.51–23.28) vs 11.23 (1.85–136.7) in survivors on admission, and it was 7.37 (2.27–26.36) in non-survivors vs 11.37 (2.78–110.9) in survivors on day 3. The ratio was significantly lower in patients with septic shock than in non-septic shock patients. The ratio had a significant negative correlation with both SOFA and APACHEII scores. The receiver operating characteristic (ROC) curve showed high accuracy of the day 1 CRP/PCT ratio to predict mortality [area under curve (AUC = 0.835)], which is comparable to the day 1 SOFA score (AUC = 0.878) and higher than the day 1 PCT and day 1 APACHE scores. Conclusion: Our results suggest a potential role for the CRP/PCT ratio, on admission and on follow-up, as a marker for predicting prognosis in sepsis patients, where low ratio values can predict poor disease outcome.

PDF Share
  1. Drăgoescu AN, Pădureanu V, Stănculescu AD, Chiuţu LC, Tomescu P, Geormăneanu et al. Neutrophil to lymphocyte ratio (NLR)-A useful tool for the prognosis of sepsis in the ICU. Biomedicines 2021;10(1):75. DOI: 10.3390/biomedicines10010075.
  2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet 2020;395(10219):200–211. DOI: 10.1016/s0140-6736(19)32989-7.
  3. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287.
  4. Newman-Toker DE, Wang Z, Zhu Y, Nassery N, Saber Tehrani AS, Schaffer AC, et al. Rate of diagnostic errors and serious misdiagnosis-related harms for major vascular events, infections, and cancers: Toward a national incidence estimate using the “Big Three”. Diagnosis (Berl) 2021;8(1):67–84. DOI: 10.1515/dx-2019-0104.
  5. Souza DC, Jaramillo-Bustamante JC, Céspedes-Lesczinsky M, Quintero EMC, Jimenez HJ, Jabornisky R, et al. Challenges and health-care priorities for reducing the burden of paediatric sepsis in Latin America: A call to action. Lancet Child Adolesc Health 2022;6(2):129–136. DOI: 10.1016/s2352-4642(21)00341-2.
  6. Bui MH, Khuong QL, Le PA, Nguyen TA, Doan QH, Duong TD, et al. Cost of postoperative sepsis in Vietnam. Sci Rep 2022;12(1):4876. DOI: 10.1038/s41598-022-08881-y.
  7. Roy S, Kothari N, Sharma A, Goyal S, Sankanagoudar S, Bhatia PK, et al. Comparison of diagnostic accuracy of presepsin and procalcitonin for sepsis in critically Ill patients: A prospective observational study. Indian J Crit Care Med 2023;27(4):289–293. DOI: 10.5005/jp-journals-10071-24439.
  8. Schuetz P, Birkhahn R, Sherwin R, Jones AE, Singer A, Kline JA, et al. Serial procalcitonin predicts mortality in severe sepsis patients: Results from the multicenter procalcitonin monitoring sepsis (MOSES) study. Crit Care Med 2017;45(5):781–789. DOI: 10.1097/ccm.0000000000002321.
  9. Park CE. Diagnosis and prognosis of sepsis. Korea J Clin Lab Sci 2021;53(4):309–316. DOI: 10.15324/kjcls.2021.53.4.309.
  10. Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: More than just fever and leukocytosis—A narrative review. Crit Care 2022;26(1):14. DOI: 10.1186/s13054-021-03862-5.
  11. Pairattanakorn P, Angkasekwinai N, Sirijatuphat R, Wangchinda W, Tancharoen L, Thamlikitkul V. Diagnostic and prognostic utility compared among different sepsis scoring systems in adult patients with sepsis in Thailand: A prospective cohort study. Open Forum Infect Dis 2021;8(1):ofaa573. DOI: 10.1093/ofid/ofaa573.
  12. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286(14):1754–1758. DOI: 10.1001/jama.286.14.1754.
  13. Larsson A, Tydén J, Johansson J, Lipcsey M, Bergquist M, Kultima K, et al. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scand J Clin Lab Invest 2020;80(2):156–161. DOI: 10.1080/00365513.2019.1703216.
  14. Giamarellos-Bourboulis EJ, Norrby-Teglund A, Mylona V, Savva A, Tsangaris I, Dimopoulou I, et al. Risk assessment in sepsis: A new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care 2012;16(4):R149. DOI: 10.1186/cc11463.
  15. Pham HM, Nguyen DLM, Duong MC, Phan XT, Tran LT, Trang DHT, et al. Neutrophil CD64-a prognostic marker of sepsis in intensive care unit: A prospective cohort study. Front Med (Lausanne) 2023;10:1251221. DOI: 10.3389/fmed.2023.1251221.
  16. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66 Suppl 2:ii33–40. DOI: 10.1093/jac/dkq523.
  17. Abdelshafey EE, Nasa P, Elgohary AE, Khalil MF, Rashwan MA, Ghezala HB, et al. Role of presepsin for the diagnosis of sepsis and ICU mortality: A prospective controlled study. Indian J Crit Care Med 2021;25(2):153–157. DOI: 10.5005/jp-journals-10071-23715.
  18. Vassallo M, Michelangeli C, Fabre R, Manni S, Genillier PL, Weiss N, et al. Procalcitonin and C-reactive protein/procalcitonin ratio as markers of infection in patients with solid tumors. Front Med (Lausanne) 2021;8:627967. DOI: 10.3389/fmed.2021.627967.
  19. Nakajima A, Yazawa J, Sugiki D, Mizuguchi M, Sagara H, Fujisiro M, et al. Clinical utility of procalcitonin as a marker of sepsis: A potential predictor of causative pathogens. Intern Med 2014;53(14):1497–1503. DOI: 10.2169/internalmedicine.53.1785.
  20. Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis 2017;4(1):ofw249. DOI: 10.1093/ofid/ofw249.
  21. Jerome E, McPhail MJ, Menon K. Diagnostic accuracy of procalcitonin and interleukin-6 for postoperative infection in major gastrointestinal surgery: A systematic review and meta-analysis. Ann R Coll Surg Engl 2022;104(8):561–570. DOI: 10.1308/rcsann.2022.0053.
  22. Lai L, Lai Y, Wang H, Peng L, Zhou N, Tian Y, et al. Diagnostic accuracy of procalcitonin compared to c-reactive protein and interleukin 6 in recognizing gram-negative bloodstream infection: A meta-analytic study. Dis Markers 2020;2020:4873074. DOI: 10.1155/2020/4 873074.
  23. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis. Lancet Infect Dis 2007;7(3):210–217. DOI: 10.1016/s1473-3099(07)70052-x.
  24. Yeh CF, Wu CC, Liu SH, Chen KF. Comparison of the accuracy of neutrophil CD64, procalcitonin, and C-reactive protein for sepsis identification: A systematic review and meta-analysis. Ann Intensive Care 2019;9(1):5. DOI: 10.1186/s13613-018-0479-2.
  25. Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F, et al. C-reactive protein and procalcitonin during course of sepsis and septic shock. Ir J Med Sci 2024;193(1):457–DOI: 468.10.1007/s11845-023-03385-8.
  26. Lee S, Song J, Park DW, Seok H, Ahn S, Kim J, et al. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: A prospective observational study according to the Sepsis-3 definitions. BMC Infect Dis 2022;22(1):8. DOI: 10.1186/s12879-021-07012-8.
  27. Silvestre J, Póvoa P, Coelho L, Almeida E, Moreira P, Fernandes A, et al. Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 2009;35(5):909–913. DOI: 10.1007/s00134-009-1402-y.
  28. Cui N, Zhang H, Chen Z, Yu Z. Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: Retrospective analysis of 59 cases. J Int Med Res 2019;47(4):1573–1579. DOI: 10.1177/0300060518822404.
  29. Hangai S, Nannya Y, Kurokawa M. Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseases. Leuk Lymphoma 2015;56(4):910–914. DOI: 10.3109/10428194.2014.938329.
  30. Hahn WH, Song JH, Kim H, Park S. Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis? J Matern Fetal Neonatal Med 2018;31(6):822–826. DOI: 10.1080/14767058.2017.1297410.
  31. Neeser OL, Vukajlovic T, Felder L, Haubitz S, Hammerer-Lercher A, Ottiger C, et al. A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection. Clin Chem Lab Med 2019;57(10):1638–1646. DOI: 10.1515/cclm-2019-0194.
  32. Fan L, Ding X. Procalcitonin and C-reactive protein/procalcitonin ratio for distinguishing between infectious and neoplastic fever in cancer patients. Altern Ther Health Med 2023;29(7):365–369. PMID: 37535912.
  33. Cho J, Jeong S, Lee JH. Procalcitonin to C-reactive protein ratio is associated with short-term mortality in ischemic stroke patients: Preliminary report. Arch Med Sci 2022;18(2):344–352. DOI: 10.5114/aoms.2020.100207.
  34. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996;22(7):707–710. DOI: 10.1007/bf01709751.
  35. Sadaka F, EthmaneAbouElMaali C, Cytron MA, Fowler K, Javaux VM, O'Brien J. Predicting mortality of patients with sepsis: A comparison of APACHE II and APACHE III scoring systems. J Clin Med Res 2017;9(11):907–910. DOI: 10.14740/jocmr3083w.
  36. Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys-Silva SA, et al. Sepsis in intensive care unit patients: Worldwide data from the intensive care over nations audit. Open Forum Infect Dis 2018;5(12):ofy313. DOI: 10.1093/ofid/ofy313.
  37. Muralidharan K. On sample size determination. Math J Interdiscip Sci 2014;3(1):55–64. DOI: 10.15415/mjis.2014.31005.
  38. Li Y, Wang J, Wei B, Zhang X, Hu L, Ye X. Value of neutrophil:lymphocyte ratio combined with sequential organ failure assessment score in assessing the prognosis of sepsis patients. Int J Gen Med 2022;15:1901–1908. DOI: 10.2147/ijgm.s348200.
  39. Kim H, Hur M, Moon HW, Yun YM, Di Somma S. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care 2017;7(1):27. DOI: 10.1186/s13613-017-0252-y.
  40. Koh JS, Kim YJ, Kang DH, Lee JE, Lee SI. Usefulness of presepsin in predicting the prognosis of patients with sepsis or septic shock: A retrospective cohort study. Yeungnam Univ J Med 2021;38(4):318–325. DOI: 10.12701/yujm.2021.01018.
  41. Hu C, Zhou Y, Liu C, Kang Y. Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock. Oncotarget 2018;9(4):5125–5136. DOI: 10.18632/oncotarget. 23701.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.